Aehr Test Systems' financials are solid, with no debt and a strong current ratio, but short-term risks pose a danger. The company has seen significant improvements in its ROA, ROE, and return on ...
Aehr's recent price drop post Q1 2024 results highlights underlying issues, questionable long-term growth potential and a discrepancy between reality and expectations. I believe the share price surge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback